Wells Fargo Lowers Marvell Price Target to $285

Analyst: Joe Quatrochi 1 min read Reproduced verbatim
Rating
Overweight
Target
$285
from $365 (−22%)
Upside
+67%
MRVL at $171 today
Wells Fargo and Marvell logos

What the analyst said

Wells Fargo analyst Joe Quatrochi lowered the price target on Marvell (NASDAQ: MRVL) to $285 (from $365) while maintaining an Overweight rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

MRVL trades at $171. The 24 analysts who set a target in the last 3 months range from $175 to $433, with a median of $300. This $285 target is 5% below the median.

12-month window: day 0 of 365, closes on November 3, 2027.

Track record

This callOpen: a 12-month target, scored on November 3, 2027, a year after the note.

Firm track recordWells Fargo: 65% of its 34 targets at least a year old were reached within 12 months (#22 of 26 firms). Accuracy ranking →

Wells Fargo on Marvell

Wells Fargo price targets on Marvell

5 calls from May 20, 2026 to November 3, 2026. The target went from $195 to $285 (+46%). The rating stayed Buy.

Wells Fargo targetMRVL share price
  1. November 3, 2026 This noteTarget cut from $365 (−22%)Buy$285
  2. October 7, 2026Target raised from $310 (+18%)Buy$365
  3. August 24, 2026Target raised from $240 (+29%)Buy$310
  4. May 28, 2026Target raised from $195 (+23%)Buy$240
  5. May 20, 2026Earliest call shownBuy$195
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.